BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 294960)

  • 1. Adriamycin/cyclophosphamide combination chemotherapy: the importance of drug scheduling.
    Mulder JH; van Putten LM
    Eur J Cancer (1965); 1979 Dec; 15(12):1503-9. PubMed ID: 294960
    [No Abstract]   [Full Text] [Related]  

  • 2. Schedule-dependent cytotoxicity of 5-fluorouracil and cyclophosphamide in experimental cancer chemotherapy.
    Mulder JH; Smink T; Ossewaarde T; van Putten LM
    Eur J Cancer (1965); 1980 May; 16(5):699-705. PubMed ID: 6930341
    [No Abstract]   [Full Text] [Related]  

  • 3. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL; Roberts D
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil and methotrexate combination chemotherapy: the effect of drug scheduling.
    Mulder JH; Smink T; van Putten LM
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):831-7. PubMed ID: 6949765
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergism and schedule dependent cytotoxicity of cyclophosphamide and CCNU in experimental cancer chemotherapy.
    Mulder JH; Edelstein MB; Lelieveld P; van Putten IM
    Eur J Cancer (1965); 1978 May; 14(5):537-42. PubMed ID: 648568
    [No Abstract]   [Full Text] [Related]  

  • 7. Circadian bioperiodic response of mice bearing advanced L1210 leukemia to combination therapy with adriamycin and cyclophosphamide.
    Scheving LE; Burns ER; Pauly JE; Halberg F
    Cancer Res; 1980 May; 40(5):1511-5. PubMed ID: 7370988
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of combined action of vitamins A, E and C and cyclophosphane or adriamycin on growth of transplanted tumors in mice].
    Mosienko VS; Khasanova LT; Sukolinskiĭ VN; Morozkina TS
    Eksp Onkol; 1990; 12(3):55-7. PubMed ID: 2344827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
    Tobias JS; Parker LM; Tattersall MH; Frei E
    Br J Cancer; 1975 Aug; 32(2):199-207. PubMed ID: 1212350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory studies of vitamin A and cyclophosphamide in tumor-bearing mice.
    Nathanson L; Maddock CL; Hall TC
    J Clin Pharmacol J New Drugs; 1969; 9(6):359-73. PubMed ID: 5260199
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of schedule in adriamycin/cyclophosphamide combination chemotherapy.
    Yesair DW; McNitt S; Tobias J; Wodinsky I
    Eur J Cancer (1965); 1978 Feb; 14(2):141-6. PubMed ID: 624311
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of adriamycin with DNA-adriamycin complex in chemotherapy of experimental tumors and metastases.
    Atassi G; Duarte-Karim M; Tagnon HJ
    Eur J Cancer (1965); 1975 May; 11(5):309-16. PubMed ID: 1157820
    [No Abstract]   [Full Text] [Related]  

  • 14. Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors.
    Bernacki RJ; Bansal SK; Gurtoo HL
    Cancer Res; 1987 Feb; 47(3):799-802. PubMed ID: 3100025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor activity of adriamycin].
    Kitaura K; Watanabe Y; Ishihara Y; Takahira H
    Jpn J Antibiot; 1972 Apr; 25(2):65-71. PubMed ID: 4341940
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative antineoplastic activity of adriamycin and N-trifluoroacetyladriamycin-14-valerate.
    Vecchi A; Cairo M; Mantovani A; Sironi M; Spreafico F
    Cancer Treat Rep; 1978 Jan; 62(1):111-7. PubMed ID: 626989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of vincristine--cyclophosphamide potentiation in different experimental tumour lines.
    Mulder JH; Lelieveld P; van Putten LM
    Eur J Cancer (1965); 1979 Apr; 15(4):499-507. PubMed ID: 436910
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA; Wodinsky I
    Cancer; 1983 Feb; 51(4):600-5. PubMed ID: 6401590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the combination of adriamycin and cyclophosphamide (alone or with other agents) for the treatment of breast cancer.
    Salmon SE; Jones SE
    Oncology; 1979; 36(1):40-7. PubMed ID: 156337
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
    Kline I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.